undamentalytics Newsletter
Sign in

Dexcom income statement

In fiscal 2025, Dexcom reported revenue of $4.66bn, up 15.6% on the year before, operating income of $912m (a 19.6% margin) and net income of $836m, or $2.09 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3049761001602594025737191,0321,4761,9272,4492,9103,6224,0334,6625,104
Cost of revenue2630405360831241952263685456477681,0271,3331,5951,8601,867
Gross profit41836471001762783784926649321,2801,6811,8832,2892,4382,8023,237
Research and development142330384569138156185200274360517484506552599608
Selling, general and administrative35415164841281982863494335166188111,0081,1851,2861,2911,406
Operating income−46−45−45−56−29−22−57−64−43−1861423002663915986009121,224
Interest expense8200110113236018191920191813
Income before tax—−55−45−56−30−22−58−65−49−1271042982573917107091,0881,262
Income tax—00−10001213−2524050169133252271
Net income−54−55−45−55−30−22−58−66−50−127101550217341542576836991
Diluted EPS−$1.21−$0.24−$0.17−$0.20−$0.10−$0.07−$0.18−$0.20−$0.14−$0.36$0.28$1.33$0.53$0.82$1.30$1.42$2.09$2.53
Diluted shares (average)—228m262m275m284m301m319m334m345m353m369m420m429m428m426m413m406m392m
EBITDA−43−43−41−49−22−13−46−49−26−1571913673685477848181,1641,499

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BLCO vs DXCMDXCM vs IDXXDXCM vs RMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Dexcom's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Dexcom.